Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-058273
Filing Date
2023-11-02
Accepted
2023-11-02 16:30:25
Documents
41
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mack-20230930.htm   iXBRL 10-Q 1014187
2 EX-31.1 mack-ex31_1.htm EX-31.1 12374
3 EX-31.2 mack-ex31_2.htm EX-31.2 12374
4 EX-32.1 mack-ex32_1.htm EX-32.1 8371
5 EX-32.2 mack-ex32_2.htm EX-32.2 8371
  Complete submission text file 0000950170-23-058273.txt   3399689

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mack-20230930_pre.xml EX-101.PRE 131731
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mack-20230930.xsd EX-101.SCH 22825
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mack-20230930_def.xml EX-101.DEF 61178
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mack-20230930_lab.xml EX-101.LAB 196218
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mack-20230930_cal.xml EX-101.CAL 20887
35 EXTRACTED XBRL INSTANCE DOCUMENT mack-20230930_htm.xml XML 461307
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35409 | Film No.: 231372874
SIC: 2834 Pharmaceutical Preparations